Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals. [electronic resource]
- Vaccine Dec 2003
- 21-9 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0264-410X
10.1016/s0264-410x(03)00538-3 doi
AIDS Vaccines--adverse effects Adult Antibodies, Viral--analysis Antibody Formation--immunology CD4-Positive T-Lymphocytes--immunology CD8-Positive T-Lymphocytes--immunology Chronic Disease Cytokines--metabolism Enzyme-Linked Immunosorbent Assay Epitope Mapping Female Follow-Up Studies Gene Products, nef--immunology HIV Infections--immunology Humans Immunity, Cellular--immunology Immunization Schedule Male Middle Aged T-Lymphocytes, Helper-Inducer--immunology Vaccines, DNA nef Gene Products, Human Immunodeficiency Virus